Description

Arg-Gly-Glu-Ser is a RGD-related peptide and a control for the RGDS ihibitory activity on fibrinogen binding to activated platelets. —Cancer-programmed cell death–C16H29N7O8—-[1]Moon C, et al. Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways. Respir Res. 2009 Mar 9;10:18.–93674-97-6–447.44—-O=C(NCC(N[C@@H](CCC(O)=O)C(N[C@@H](CO)C(O)=O)=O)=O)[C@H](CCCNC(N)=N)N–Cancer–H2O : 2 mg/mL (ultrasonic;warming)–Others—-Others–Peptides